Shield Tx Company Profile
What is the competitive landscape for SHIELD TX
SHIELD TX has one approved drug.
There are three US patents protecting SHIELD TX drugs.
Summary for Shield Tx
| US Patents: | 3 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Shield Tx
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shield Tx | ACCRUFER | ferric maltol | CAPSULE;ORAL | 212320-001 | Jul 25, 2019 | RX | Yes | Yes | 9,248,148 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Shield Tx | ACCRUFER | ferric maltol | CAPSULE;ORAL | 212320-001 | Jul 25, 2019 | RX | Yes | Yes | 9,802,973 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Shield Tx | ACCRUFER | ferric maltol | CAPSULE;ORAL | 212320-001 | Jul 25, 2019 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Shield Tx | ACCRUFER | ferric maltol | CAPSULE;ORAL | 212320-001 | Jul 25, 2019 | RX | Yes | Yes | 10,179,120 | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Shield Tx Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 102576930 | ⤷ Start Trial |
| European Patent Office | 2303289 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2015101971 | ⤷ Start Trial |
| United Kingdom | 201419174 | ⤷ Start Trial |
| China | 114010629 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
